ExAblate is the only commercially  approved non-invasive treatment for uterine fibroids using MR guided Focused Ultrasound.   InSightec is conducting research for oncology applications such as pain palliation of bone metastases, breast and prostate cancer.

ExAblate using non-invasive MR guided focused ultrasound technology has the potential to offer non-invasive treatment for a wide variety of applications as an alternative to invasive procedures. When you become a Research Partner with InSightec, you become an active participant in our progress toward non-invasive tumor ablation.

• MR guided focused ultrasound provides a therapeutic effect by raising the tissue temperature of the target high enough to destroy it
• Non-ionizing radiation
• Minimal treatment-related side effects
• Treatments can be repeated as often as required
• 3D visualization, before, during and after treatment for continuous monitoring and control of treatment

Join the InSightec fan page on Facebook.